Platelet Rich Plasma Market To Reach $1,751.45 Million By 2033

February 2026 | Report Format: Electronic (PDF)

Platelet Rich Plasma Market Growth & Trends

The global platelet rich plasma market size is estimated to reach USD 1,751.45 million by 2033, registering a CAGR of 13.2% from 2026 to 2033, according to a new report by Grand View Research, Inc. Rising number of cosmetic surgeries, increasing national and international sporting events, and extending research in plasma-based therapies are fueling the industry growth. Furthermore, R&D activities and regulatory approvals of platelet rich plasma (PRP) based treatments are key market drivers.

Currently, there has been an upsurge in demand for use of PRP in the treatment of sports injuries, orthopedic disorders, and musculoskeletal conditions. It concentrates on growth factors and can significantly reduce healing time. PRP also finds major application in the regenerative medicine field and serves as a custom product for each patient speeding up wound healing and repair cascade.

Platelet rich plasma has evolved in plastic surgery with promising results to utilize the body’s own natural tissue repair process to achieve improved form and function. The characteristics such as ease of use, inexpensive to produce utilizing patient’s cells, and little or no risk of adverse reactions are the main advantages offered by PRP therapies. However, treatment has been time consuming and requires multiple sessions. Moreover, it helps in skin rejuvenation, skin pigmentation, treating acne scars, and skin tightening during vampire facials. PRP is used as a supplement for hair transplant, which helps in the formation and maintenance of hair follicles. Thus, the widespread uses of platelet rich plasma are anticipated to fuel industry growth.

Furthermore, the key players are implementing strategic initiatives such as mergers and acquisitions, product development, and business expansions to enter the market. In September 2021, Terumo BCT expanded its presence in Costa Rica with the opening of a new manufacturing facility in La Lima, Cartago, with the view to expand its customer base in the U.S. In February 2020, EmCyte Co. acquired Cellmedix Holdings LLC, with its Centrepid platelet concentrator system. This expanded the company’s product portfolio and improved its market presence.

In light of COVID-19, the market witnessed a significant setback due to supply chain disruption, constraints in resource allocation, and hindrances in patient access activities, among other reasons. However, by January 2022, the market got stabilized and continue to normalize demand and supply, and users and patients regain access to platelet-rich plasma.

key Request a free sample copy or view report summary: Platelet Rich Plasma Market Report

Platelet Rich Plasma Market Report Highlights

Based on type, the pure PRP segment dominated the market with the largest revenue share of 51.12% in 2025, as it represents the most clinically accepted and operationally scalable PRP formulation.
Based on end-use, the hospitals segment dominated the platelet rich plasma market with a share of 48.57% in 2025, reflecting the concentration of PRP use in settings that manage high patient volumes and complex musculoskeletal cases.
Based on application, the orthopedics segment dominated the market with the largest revenue share of 25.38% in 2025, as musculoskeletal conditions represent the most established and recurrent use case for PRP therapies.
North America platelet rich plasma market accounting for 42.00% of global revenue, supported by high adoption in orthopedics, sports medicine, and aesthetics.

Platelet Rich Plasma Market Segmentation

Grand View Research has segmented the global platelet rich plasma (PRP) market based on type, application, end-use, and region:

Platelet Rich Plasma Type Outlook (Revenue, USD Million, 2021 - 2033)

Pure PRP
Leukocyte Rich PRP
Others

Platelet Rich Plasma Application Outlook (Revenue, USD Million, 2021 - 2033)

Orthopedics
Sports Medicine
Cosmetic Surgery
Dermatology
- Ulcer Healing
  - Venous Ulcer
  - Traumatic Ulcer
  - Diabetic Ulcer
  - Pyoderma Gangrenosum Ulcer
  - Trophic Ulcer
  - Vasculitic Ulcer
  - Others
- Others
Ophthalmic Surgery
Neurosurgery
General Surgery
Others